Regensis is actively involved in national and international R&D projects supported by public and private institutions. We collaborate with academic groups and biotech firms to develop innovative therapies and platforms. In this section, we highlight our ongoing and completed projects, including those funded by TÜBİTAK and EU Horizon programs.
Details are on the way…